TNF and neoplasm: In a combination approach, Su et al. evaluated to which extent systemic TNF-α gene therapy synergized with liposomal doxorubicin (Doxil®) to enhance tumor endothelium permeability, and thus would promote accumulation of the chemotherapeutic drug within the tumor [345].